High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure
about
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrheaDrug Resistance Mechanisms in Bacteria Causing Sexually Transmitted Diseases and Associated with VaginosisCurrent and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challengeThe effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic reviewAntimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and futurePreparing for an era of untreatable gonorrheaResistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding ProteinsHigh-throughput screening for novel inhibitors of Neisseria gonorrhoeae penicillin-binding protein 2Gonorrhea - an evolving disease of the new millennium.Neisseria gonorrhoeae Evades Calprotectin-Mediated Nutritional Immunity and Survives Neutrophil Extracellular Traps by Production of TdfH.Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum.Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia, 2009-2013.Population structure of Neisseria gonorrhoeae based on whole genome data and its relationship with antibiotic resistance.Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales.Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative actionTrends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USALipid a is more than acyl chainsAntimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae.Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.Conjunctivitis Caused by a Strain of Neisseria gonorrhoeae That Was Less Susceptible to Ceftriaxone.High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.Insights in public health: The hidden epidemic: sexually transmitted diseases in 2014.Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin.Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of HungaryUsing crude whole-genome assemblies of Neisseria gonorrhoeae as a platform for strain analysis: clonal spread of gonorrhea infection in Saskatchewan, Canada.Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012.Sexually transmitted diseases treatment guidelines, 2015.Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011.Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.Structural effect of the Asp345a insertion in penicillin-binding protein 2 from penicillin-resistant strains of Neisseria gonorrhoeae.The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrheaWhole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolatesAntimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.
P2860
Q24633203-BB7CF3A1-DB86-4009-84BE-0A33F262B8A4Q26744660-D796B055-06E8-4E78-B04E-70E69B569022Q26796265-A96766D0-7C24-4282-AC25-29B3AAD212ADQ26825614-4F503B96-E184-4B0A-8912-6AEF453BCD35Q26862597-72902BB4-8BC6-4302-BDD6-DE6C1DAE1218Q27002771-98160701-CEBC-4FDF-8E02-29C054AA58D4Q28080009-06EEA139-B051-469E-B25C-79854A4FC77BQ28484022-0056F7BF-9A7F-46B4-9FB3-260CC92AC463Q30235031-A98B2898-C460-4655-B9BF-19AA67D34B07Q30276223-48D3E606-3FCC-4A5C-855B-AA0D415DD9F7Q30391042-4AC0E0B6-31BB-41A1-BA03-8614D0CE1C03Q30724177-CB3C8531-10E0-4BCC-9DCF-B4EA1DAB7385Q30865577-1C1D85DF-BE4B-4130-8550-80C4FD1F05FDQ30911714-2348A65F-72CD-4826-B7EB-A75C4F8F6891Q31112740-9BBCFFAA-11D3-42B5-BA43-9FC60563FC9AQ32383726-50733496-166C-465A-B098-C4080ABEA2F7Q33553128-144DAAF8-B35E-4325-B4E4-CA8AD95B9C38Q33597163-BFC2C22E-4917-49EA-9725-687876A6EB1FQ33602966-74D4D8B8-E5D9-4931-9293-F166EEC002A1Q33730287-7D9CB412-6786-4C64-BE74-F4C10D5C213CQ33797845-7CA6841F-83C8-41B0-B2DB-7D64F9433263Q33822930-C60B9ECA-5430-480A-82AC-D0477281B2F5Q33836057-D983B679-CBC1-4F65-AEA1-CC37F4A4DC9BQ33874740-9BC577BA-24CD-4489-BE87-F94E7463719DQ34057315-0DE32BA1-1965-418D-BBE6-3AA1BF59FF94Q34081308-5C1CEA8F-2591-4589-9EA2-9A571BE6EC37Q34123726-9D56CCB6-7CEF-42C9-8BD3-15636EE108DAQ34136098-71BA5125-0D68-4091-875D-6ECEC012001AQ34298188-6C5BF96A-CB88-4883-8052-1AC3B073C6ABQ34298905-B2381B3E-2DF4-4E82-BAA6-0C049642B017Q34479272-D6B278FB-6A02-434F-8503-5F20031DB1AEQ34529360-75A10B04-887B-4270-9C10-12ECF275BA1EQ34561067-B21A0426-908F-4569-AA54-F0379CA5F0E9Q34563908-4615DC71-794E-46C7-953E-C41AF294E56BQ34677116-002C5C65-22C5-4C63-B186-ADA11B14AC99Q34680258-5F8CD15F-77DA-42CE-9DBD-277345CA08FDQ34736808-1B521F14-9912-4FAB-AE32-D6619D1B1245Q34916494-65060652-5E92-46CD-9CD4-B11C7D5BAEE4Q35076855-73F59657-F661-4938-852E-7749586B3349Q35087427-E8A3809A-57BB-46D0-8E60-A81694647E5F
P2860
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
High-level cefixime- and ceftr ...... clone causes treatment failure
@ast
High-level cefixime- and ceftr ...... clone causes treatment failure
@en
type
label
High-level cefixime- and ceftr ...... clone causes treatment failure
@ast
High-level cefixime- and ceftr ...... clone causes treatment failure
@en
prefLabel
High-level cefixime- and ceftr ...... clone causes treatment failure
@ast
High-level cefixime- and ceftr ...... clone causes treatment failure
@en
P2093
P2860
P356
P1476
High-level cefixime- and ceftr ...... clone causes treatment failure
@en
P2093
Anne Gallay
Makoto Ohnishi
Patrice Sednaoui
Robert Nicholas
P2860
P304
P356
10.1128/AAC.05760-11
P407
P577
2011-12-12T00:00:00Z